Publications and communications of Clio RIBBENS

Malaise, O., & Ribbens, C. (January 2024). LES GLUCOCORTICOïDES EN MEDECINE GENERALE ? OUI … ? NON … ? Oui, mais avec modération ? [Paper presentation]. Enseignement Post Universitaire de la Faculté de Médecine de l'ULiège.

Bouquegneau, A., Mina, M., GERARD, C., Rinkin, C., Seidel, L., Ribbens, C., & Malaise, O. (2023). Le TBS (Trabecular Bone Score) peut-il prédire la microarchitecture osseuse observée par microscanner osseux périphérique dans deux populations d’ostéoporose secondaire ? Revue du Rhumatisme.

Peters, C.* , Malaise, O.* , Longton, J., André, B., & Ribbens, C. (December 2023). Vignette thérapeutique de l’étudiant. Prise en charge de la goutte. Revue Médicale de Liège, 78 (12), 733 - 739.

DENIS, A., Frix, A.-N., NGUYEN DANG, D., Malaise, O., DEFOURNY, C., Lovinfosse, P., Corhay, J.-L., GESTER, F., Louis, R., Ribbens, C., & Guiot, J. (November 2023). La pathologie pulmonaire associée à la polyarthrite rhumatoïde. Revue Médicale de Liège, 78 (11), 641-648.

Malaise, O., Bolland, M., & Ribbens, C. (October 2023). Vignette diagnostique de l’étudiant. Prise en charge diagnostique de l’ostéoporose. Revue Médicale de Liège, 78 (10), 586 - 592.

Bolland, M., Malaise, O., Seidel, L., Meunier, P., Ribbens, C., & Von Frenckell, C. (September 2023). Systematic screening of swallowing disorders in idiopathic inflammatory myopathies: a retrospective study [Paper presentation]. Belgian Congress of Rheumatology.

Malaise, O., Bouquegneau, A., Seidel, L., GERARD, C., Rinkin, C., & Ribbens, C. (September 2023). Can “Trabecular Bone Score” predict bone micro-architecture in patients with rheumatoid arthritis or chronic kidney disease ? [Paper presentation]. Belgian Congress of Rheumatology.

Salpetier, P., Mina, M., Seidel, L., Ribbens, C., & Malaise, O. (September 2023). Comparison between « systematic » versus « recommendation-based » Vertebral Fracture Assessment realization during Dual Energy X-ray Absorptiometry examination [Paper presentation]. Belgian Congress of Rheumatology.

Massenet, T., Potjewijd, J., Henket, M., Gridelet, G., Zanella, D., Dejong, T., GILTAY, L., GESTER, F., GUISSARD, F., André, B., Ribbens, C., Van Paassen, P., Louis, R., Focant, J.-F., Guiot, J.* , & Stefanuto, P.-H.*. (20 June 2023). Breath analysis to diagnose and assess systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry [Poster presentation]. Metabolomics 2023, Niagara Falls, Canada.

Mina, M., Salpetier, P., Seidel, L., Ribbens, C., & Malaise, O. (2023). Comparison between « systematic » versus « recommendation-based » Vertebral Fracture Assessment (VFA) realization during Dual Energy X-ray Absorptiometry examination. Annals of the Rheumatic Diseases.

Rinkin, C., CHAUVEHEID, F., GERARD, C., Seidel, L., Hustinx, R., Ribbens, C., & Malaise, O. (2023). [18F] positron emission computed tomography ([18F] FDG PET/CT) is able to predict ultrasound-defined remission in rheumatoid arthritis. Annals of the Rheumatic Diseases.

Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6

Bolland, M., Malaise, O., & Ribbens, C. (April 2023). Une nouveauté dans la prise en charge de l’ostéoporose post-ménopausique à très haut risque fracturaire : le romosozumab (Evenity®), un anticorps monoclonal anti-sclérostine. Revue Médicale de Liège, 78 (4), 239 - 244.

Malaise, O., André, C., Van Durme, C., Seidel, L., Schleich, F., Louis, R., Malaise, M., & Ribbens, C. (20 March 2023). Lung Function Impairment, Associating Hyperinflation with Impaired Diffusion Capacity and Transfer Coefficient, Is a Risk Factor for Hip Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine, 12 (6), 2383. doi:10.3390/jcm12062383

Lehane, F., Von Frenckell, C., Docampo Martínez, E., Ribbens, C., & Malaise, O. (March 2023). Fibromyalgia … 
But does your liver agree with this diagnosis? [Paper presentation]. Bone Curriculum Symposium 2023.

Salpetier, P., Mina, M., Seidel, L., LEROY, M., LEONORI, L., Malaise, M., Ribbens, C., & Malaise, O. (2022). Réalisation « systématique » ou « basée sur les recommandations » d’une radiographie du rachis dorsolombaire (Vertebral Fracture Assessment) lors d’un examen de densitométrie osseuse ? Revue du Rhumatisme. doi:10.1016/j.rhum.2022.10.152

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., MALAISE, M., & MALAISE, O. (March 2021). Systematic analysis of Covid-19 infection and symptoms in a systemic lupus erythematous population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments [Paper presentation]. Belgian congress of rheumatology 2021.

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375.

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., Malaise, M., & MALAISE, O. (2020). Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2020-218244

Varkas, G., RIBBENS, C., Louis, E., Van den Bosch, F., Lories, R., Vermeire, S., Elewaut, D., & De Vos, M. (2019). Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies. Alimentary pharmacology & therapeutics, 50 (11-12), 1204-1213. doi:10.1111/apt.15519

Hauzeur, J.-P., Kaiser, M.-J., DEFLANDRE, E., Ribbens, C., & Rinkin, C. (2017). non OMERACT-expert rheumatologists sonographers and inter-ultrasound machine reliability of the OMERACT ultrasound scoring in rheumatoid arthritis in a clinical-based setting: a belgian study. In KBVR poster display and abstracts. Belgium: KBVR.

SIMONI, P., Gerard, L., KAISER, M.-J., RIBBENS, C., RINKIN, C., MALAISE, O., & Malaise, M. (2015). Use of Tomosynthesis for Detection of Bone Erosions of the Foot in Patients With Established Rheumatoid Arthritis: Comparison With Radiography and CT. American Journal of Roentgenology, (205), 364-370. doi:10.2214/AJR.14.14120

RIBBENS, C., & Namur, G. (2015). Bone scintigraphy and positron emission tomography. In M. Hochberg, Rheumatology. Philadelphia, Unknown/unspecified: Saunders, Elsevier. doi:10.1016/B978-0-323-09138-1.00043-7

DE SENY, D., Sharif, M., Fillet, M., COBRAIVILLE, G., Meuwis, M.-A., Marée, R., HAUZEUR, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., Kirwan, J., Ribbens, C., & Malaise, M. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Annals of the Rheumatic Diseases, 70 (6), 1144-52. doi:10.1136/ard.2010.135541

Boonen, A., vander Cruyssen, B., de Vlam, K., Steinfeld, S., RIBBENS, C., Lenaerts, J., Van den Bosch, F., Mielants, H., Dewulf, L., & Vastesaeger, N. (June 2009). Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. Journal of Rheumatology, 36 (6), 1249-55. doi:10.3899/jrheum.080831

De Seny, D., Ribbens, C., Cobraiville, G., Meuwis, M.-A., Marée, R., Geurts, P., Wehenkel, L., Louis, E., Merville, M.-P., Fillet, M., & Malaise, M. (2009). Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt. Revue Médicale de Liège, 64 (Spec No), 29-35.

RIBBENS, C., & HUSTINX, R. (2009). Nuclear (scintigraphic) methods and FDG-PET in rheumatoid arthritis and osteoarthritis. In M. A. Bruno (Ed.), Arthritis in Color. Advance Imaging of Arthritis. Philadelphia, Unknown/unspecified: Saunders, Elsevier. doi:10.1016/B978-1-4160-4722-3.00007-0

De Seny, D., Fillet, M., Ribbens, C., Marée, R., Meuwis, M.-A., Lutteri, L., Chapelle, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., & Malaise, M. (2008). Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clinical Chemistry, 54, 1066-1075. doi:10.1373/clinchem.2007.099549

Delleuze, P.-P., CANIVET, J.-L., PREISER, J.-C., RIBBENS, C., MASSION, P., & Damas, P. (2008). Churg Strauss Syndrome masquerading septic shock. Acta Clinica Belgica, 63 (4), 269-72. doi:10.1179/acb.2008.049

Vander Cruyssen, B., RIBBENS, C., Boonen, A., Mielants, H., de Vlam, K., Lenaerts, J., Steinfeld, S., Van den Bosch, F., Dewulf, L., & Vastesaeger, N. (August 2007). The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Annals of the Rheumatic Diseases, 66 (8), 1072-7. doi:10.1136/ard.2006.064543

Paquet, P., Ribbens, C., & Pierard, G. (2007). Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis. Clinical and Experimental Dermatology, 32 (6), 728-32. doi:10.1111/j.1365-2230.2007.02482.x

Beckers, C., Jeukens, X., Ribbens, C., Andre, B., Marcelis, S., Leclercq, P., Kaiser, M.-J., Willems, J., Hustinx, R., & Malaise, M. (March 2006). F-18-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. European Journal of Nuclear Medicine and Molecular Imaging, 33 (3), 275-280. doi:10.1007/s00259-005-1952-3

BECKERS, C., BERNARD, C., KAISER, M.-J., RIBBENS, C., MALAISE, M., & HUSTINX, R. (2005). Time-course study of (F-18)-FDG uptake in psoriatic synovitis. Journal of Nuclear Medicine, 46 (SUPPL), 183.

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607

Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relic, B., Chariot, A., Bours, V., Piette, J., Merville, M.-P., & Malaise, M. (2005). Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism, 52 (1), 84-93. doi:10.1002/art.20727

Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964.

Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.-J., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2004). 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Journal of Biological Chemistry, 279 (21), 399-403. doi:10.1074/jbc.M314118200

Franchimont, N. M., Lambert, C., Ribbens, C., Huynen, P., Relic, B., Bours, V., Merville, M.-P., & Malaise, M. (September 2003). Interleukin-1beta and tumor necrosis factor-alpha enhance the shedding of Interleukin-6 receptor in osteoblastic cells: Involvement of tumor necrosis factor-alpha converting enzyme. Arthritis and Rheumatism, 48 (9, Suppl. S), 482.

Lambert, C., Ribbens, C., Bours, V., Merville, M.-P., Malaise, M., & Franchimont, N. (September 2003). Identification of the signalling pathways required for interleukin-1 beta stimulation of osteoprotegerin synthesis in osteoblastic cells. Journal of Bone and Mineral Research, 18 (Suppl. 2), 142.

Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., Bonnet, V., Beckers, C., & Malaise, M. (2003). Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. Radiology, 229 (2), 562-569. doi:10.1148/radiol.2292020206

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). FDG-PET imaging for monitoring rheumatoid arthritis treated by infliximab injections. Journal of Nuclear Medicine, 43, 38.

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). Characterization of inflamed joints in rheumatoid arthritis patients using FDG-PET: correlation with clinical and ultrasonographical assessment. Journal of Nuclear Medicine, 43, 38.

Relic, B., Bentires-Alj, M., Ribbens, C., Franchimont, N., Guerne, P.-A., Benoit, V., Merville, M.-P., Bours, V., & Malaise, M. (2002). TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Laboratory Investigation, 82 (12), 1661-1672. doi:10.1097/01.LAB.0000041714.05322.C0

Ribbens, C., Martin y Porras, M., Franchimont, N., Kaiser, M.-J., Jaspar, J. M., Damas, P., Houssiau, F. A., & Malaise, M. (2002). Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Annals of the Rheumatic Diseases, 61 (2), 161-166. doi:10.1136/ard.61.2.161

Ribbens, C., Andre, B., Kaye, O., & Malaise, M. (2001). Actualités thérapeutiques de la polyarthrite rhumatoïde. Revue de la Médecine Générale, 186, 372-376.

Ribbens, C., & Malaise, M. (2001). La stromelysine-1 en pathologie inflammatoire: signification, specificite et elements de regulation. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 156 (5-6), 275-281, discussion 281-283.

Louis, E., Ribbens, C., Barreto Dos Santos, A., Franchimont, D., De Groote, D., Hardy, N., Boniver, J., Belaiche, J., & Malaise, M. (May 2000). Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clinical and Experimental Immunology, 120 (2), 241-246. doi:10.1046/j.1365-2249.2000.01227.x

RIBBENS, C., Dayer, J. M., & Chizzolini, C. (February 2000). CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes. Immunology, 99 (2), 279-86. doi:10.1046/j.1365-2567.2000.00948.x

Baron, F., Ribbens, C., Kaye, O., Fillet, G., Malaise, M., & Beguin, Y. (2000). Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. British Journal of Haematology, 110 (2), 339-342. doi:10.1046/j.1365-2141.2000.02191.x

RIBBENS, C. (2000). La stromélysine-1 en pathologie inflammatoire rhumatologique. Corrélations biologiques, intérêt clinique et éléments de régulation synoviale [Doctoral thesis, ULg - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/289862

Ribbens, C., Andre, B., Jaspar, J. M., Kaye, O., Kaiser, M.-J., De Groote, D., & Malaise, M. (2000). Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. Journal of Rheumatology, 120 (1), 888-893.

Ribbens, C., Andre, B., Kaye, O., Kaiser, M. J., Bonnet, V., de Groote, D., Franchimont, N., & Malaise, M. (2000). Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. European Cytokine Network, 11 (4), 669-676.

Ribbens, C., Andre, B., Kaye, O., Kaiser, M. J., Bonnet, V., Jaspar, J. M., de Groote, D., Franchimont, N., & Malaise, M. (2000). Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology, 39 (12), 1357-1365. doi:10.1093/rheumatology/39.12.1357

Ribbens, C., Bonnet, V., Kaiser, M.-J., Andre, B., Kaye, O., Franchimont, N., De Groote, D., Beguin, Y., & Malaise, M. (2000). Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clinical and Experimental Immunology, 120 (1), 194-199. doi:10.1046/j.1365-2249.2000.01198.x

Chizzolini, C., Rezzonico, R., RIBBENS, C., Burger, D., Wollheim, F. A., & Dayer, J.-M. (November 1998). Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Arthritis and Rheumatism, 41 (11), 2039-47. doi:10.1002/1529-0131(199811)41:11

Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (April 1997). Les manifestations osteo-articulaires du sujet âgé. Revue Médicale de Liège, 52 (4), 270-277.

Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (1997). Ciclosporine et maladies systémiques. Médecine et Hygiène, 55, 1510-1514.

Kaye, O., Ribbens, C., Kahn, M. F., & Malaise, M. (1997). Sarcoidosis: recognition and treatment guidelines. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 7 (6), 441-447. doi:10.2165/00063030-199707060-00003

Pirenne, J., RIBBENS, C., Medot, M., De Groote, D., Vrindts, Y., Lopez, M., GATHY, R., Franchimont, P., & Jacquet, N. (February 1995). Adverse effect of abdominal operations on production of interferon-gamma. The European journal of surgery = Acta chirurgica, 161 (2), 77-83.

Kaye, O., Ribbens, C., Hauwaert, C., & Malaise, M. (1995). Toxicité potentielle et utilisation pratique du méthotrexate dans la polyarthrite rhumatoïde. Médecine et Hygiène, 1625-1628.

Kaye, O., Ribbens, C., Hauwaert, C., & Malaise, M. (1995). Le méthotrexate en rhumatologie: une révolution thérapeutique. Revue Médicale de Liège, 50 (11), 453-457.

Delree, P., Ribbens, C., Martin, D., Rogister, B., LEFEBVRE, P., Rigo, J.-M., Leprince, P., Schoenen, J., & Moonen, G. (1993). Plasticity of Developing and Adult Dorsal Root Ganglion Neurons as Revealed in Vitro. Brain Research Bulletin, 30 (3-4), 231-7. doi:10.1016/0361-9230(93)90249-B